68 related articles for article (PubMed ID: 27174320)
41. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.
Cao W; Fan R; Wang L; Cheng S; Li H; Jiang J; Geng M; Jin Y; Wu Y
Tumour Biol; 2013 Apr; 34(2):963-71. PubMed ID: 23264087
[TBL] [Abstract][Full Text] [Related]
42. Alternative cleavage and polyadenylation during colorectal cancer development.
Morris AR; Bos A; Diosdado B; Rooijers K; Elkon R; Bolijn AS; Carvalho B; Meijer GA; Agami R
Clin Cancer Res; 2012 Oct; 18(19):5256-66. PubMed ID: 22874640
[TBL] [Abstract][Full Text] [Related]
43. A quantitative atlas of polyadenylation in five mammals.
Derti A; Garrett-Engele P; Macisaac KD; Stevens RC; Sriram S; Chen R; Rohl CA; Johnson JM; Babak T
Genome Res; 2012 Jun; 22(6):1173-83. PubMed ID: 22454233
[TBL] [Abstract][Full Text] [Related]
44. Identifying microRNA/mRNA dysregulations in ovarian cancer.
Miles GD; Seiler M; Rodriguez L; Rajagopal G; Bhanot G
BMC Res Notes; 2012 Mar; 5():164. PubMed ID: 22452920
[TBL] [Abstract][Full Text] [Related]
45. Targeting survivin in cancer.
Altieri DC
Cancer Lett; 2013 May; 332(2):225-8. PubMed ID: 22410464
[TBL] [Abstract][Full Text] [Related]
46. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
[TBL] [Abstract][Full Text] [Related]
47. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing.
Fu Y; Sun Y; Li Y; Li J; Rao X; Chen C; Xu A
Genome Res; 2011 May; 21(5):741-7. PubMed ID: 21474764
[TBL] [Abstract][Full Text] [Related]
48. Gene silencing by microRNAs: contributions of translational repression and mRNA decay.
Huntzinger E; Izaurralde E
Nat Rev Genet; 2011 Feb; 12(2):99-110. PubMed ID: 21245828
[TBL] [Abstract][Full Text] [Related]
49. Mammalian microRNAs predominantly act to decrease target mRNA levels.
Guo H; Ingolia NT; Weissman JS; Bartel DP
Nature; 2010 Aug; 466(7308):835-40. PubMed ID: 20703300
[TBL] [Abstract][Full Text] [Related]
50. Increasing specificity of real time PCR to detect microRNA through primer design and annealing temperature increase.
He XJ; Zhang Q; Liu YJ; Pan XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 41(6):691-8. PubMed ID: 20019783
[TBL] [Abstract][Full Text] [Related]
51. Survivin as a global target of intrinsic tumor suppression networks.
Guha M; Altieri DC
Cell Cycle; 2009 Sep; 8(17):2708-10. PubMed ID: 19717980
[TBL] [Abstract][Full Text] [Related]
52. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells.
Mayr C; Bartel DP
Cell; 2009 Aug; 138(4):673-84. PubMed ID: 19703394
[TBL] [Abstract][Full Text] [Related]
53. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets.
Andersen CL; Jensen JL; Ørntoft TF
Cancer Res; 2004 Aug; 64(15):5245-50. PubMed ID: 15289330
[TBL] [Abstract][Full Text] [Related]
54. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
Mirza A; McGuirk M; Hockenberry TN; Wu Q; Ashar H; Black S; Wen SF; Wang L; Kirschmeier P; Bishop WR; Nielsen LL; Pickett CB; Liu S
Oncogene; 2002 Apr; 21(17):2613-22. PubMed ID: 11965534
[TBL] [Abstract][Full Text] [Related]
55. Aberrant Alternative Polyadenylation is Responsible for Survivin Up-regulation in Ovarian Cancer.
He XJ; Zhang Q; Ma LP; Li N; Chang XH; Zhang YJ
Chin Med J (Engl); 2016 May; 129(10):1140-6. PubMed ID: 27174320
[TBL] [Abstract][Full Text] [Related]
56. Implications of polyadenylation in health and disease.
Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
[TBL] [Abstract][Full Text] [Related]
57. Modulation of untranslated region alternative polyadenylation in glioma tumorigenesis.
Lan YL; Zhang J
Biomed Pharmacother; 2021 May; 137():111416. PubMed ID: 33761620
[TBL] [Abstract][Full Text] [Related]
58. Translating the Untranslated Region.
Schwerk J; Savan R
J Immunol; 2015 Oct; 195(7):2963-71. PubMed ID: 26386038
[TBL] [Abstract][Full Text] [Related]
59. Alternative Polyadenylation in Stem Cell Self-Renewal and Differentiation.
Sommerkamp P; Cabezas-Wallscheid N; Trumpp A
Trends Mol Med; 2021 Jul; 27(7):660-672. PubMed ID: 33985920
[TBL] [Abstract][Full Text] [Related]
60. Alternative polyadenylation and its impact on cellular processes.
Akman HB; Erson-Bensan AE
Microrna; 2014; 3(1):2-9. PubMed ID: 25069507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
